Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ANPEP | P15144 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL840430 | 0.83 | MEN1 (0.40) | ALDH1A1CYP2D6TDP1L3MBTL1ABCB1 | |
| SCHEMBL31758131 | 0.83 | MEN1 (0.45) | ALDH1A1CYP2D6TDP1L3MBTL1ABCB1 | |
| SCHEMBL840429 | 0.83 | MEN1 (0.40) | ALDH1A1CYP2D6TDP1L3MBTL1ABCB1 | |
| SCHEMBL1816293 | 0.82 | ALDH1A1 (0.64) | USP2ALDH1A1TDP1ANPEPNPC1 | |
| SCHEMBL4223348 | 0.81 | USP2 (0.47) | USP2ALDH1A1CYP2D6ANPEPNPC1 | |
| Hydrochloric Acid SCHEMBL5967015 | 0.81 | ALDH1A1 (0.53) | USP2ALDH1A1TDP1ANPEPNPC1 | |
| SCHEMBL31757733 | 0.77 | ALDH1A1 (0.61) | USP2ALDH1A1ANPEPNPC1L3MBTL1 | |
| SCHEMBL5655509 | 0.77 | ALDH1A1 (0.45) | USP2ALDH1A1CYP2D6TDP1ANPEP | |
| SCHEMBL16415872 | 0.77 | ALDH1A1 (0.45) | USP2ALDH1A1CYP2D6TDP1ANPEP | |
| SCHEMBL5418111 | 0.76 | GLA (0.51) | ALDH1A1L3MBTL1LMNASMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008758-A1 | LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF | INSMED INCORPORATED | 2026-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008758-A1 | LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF | DPP3, DPP7, DPP9 | USP2 2150/4885ALDH1A1 341/4885CYP2D6 248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.